@
@ ‚g‚n‚l‚d(ƒŠƒ“ƒN‚c‚dƒ_ƒCƒGƒbƒg) @@ Œ’N‰h—{๎•๑’T๕ƒy[ƒW @@ ‘—งŒ’NE‰h—{Œค‹†Š

˜_•ถW‚ษ–฿‚้ ‰hŒคƒXƒ^ƒbƒt‚ษ‚ๆ‚้‰๐เ˜_•ถW Ž‘—ฟ@์ฌ“๚@98/01/20
Disposition of quercetin in man after single oral and intravenous doses
’˜Žา: Gugler, R., Leschik, M. and Dengler, H. J.
o“T: Europ. J. clin. Phamacol, 9, 229-234(1975)


—v–๑

The pharmacokinetics of quercetin, a flavonoid, have been studied in 6 volunteers after single intravenous (100 mg) and oral (4 g) doses. The data after iv administration were analyzed according to a two compartment open model with half lives of 8.8 } 1.2 min for the@ƒฟphase and 2.4 } 0.2 h for the ƒภPhase (predominant half life) , respectively. Protein binding was >98%. The apparent volume of distribution was small at 0.34 } 0.03 l/kg. Of the intravenous dose 7.4} 1.2% was excreted in urine as a conjugated metabolite, and 0.65 } 0.1% was excreted unchanged. After oral administration no measurable plasma concentrations could be detected, nor was any quercetin found in urine, either unchanged or in a metabolized form. These results exclude absorption of more than 1% of unchanged drug. Recovery in faeces after the oral dose was 53 } 5%, which suggests extensive degradation by microorganisms in the gut. The data obtained show that oral administration of flavonoids may be of questionable value.


@(c) All Copyrights reserved 2001 National Institute of Health and Nutrition